The data could help the Enhertu regimen overtake a drug combination that’s been used as the initial treatment for ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

The leaked budget draft, if approved by Congress, would reduce the FDA’s budget authority, indicating more disruption could ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

The company’s board reiterated its recommendation to instead pursue an offer from SK Capital and Carlyle that’s worth about ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also ...